Gauthey L, Toscani L, Schira J C
Soz Praventivmed. 1997;42 Suppl 2:S107-11. doi: 10.1007/BF01365164.
Influenza is still an important cause of morbidity and mortality in our country. The yearly vaccination of the population at risk is always the best method of prevention and for the limitation of health care costs. Today the protection of elderly people and health care professionals by vaccination is not sufficient. Development of information programs, sensibilisation and motivation of the community on a national basis and in line with the health care insurers are necessary. The vaccine's reimbursement since 1996 following the respective legal change will certainly help to promote vaccination against influenza. On the other hand, the competition of different vaccines introduced in Switzerland in the last years will additionally support the penetration of information and vaccination.
在我国，流感仍是发病和死亡的一个重要原因。对高危人群进行年度疫苗接种始终是最佳预防方法，也是限制医疗保健成本的方法。如今，通过接种疫苗对老年人和医护人员的保护并不充分。开展信息项目、在全国范围内并与医疗保险机构合作提高社区的认识和积极性很有必要。自1996年法律变更后疫苗可报销这一举措肯定有助于推动流感疫苗接种。另一方面，过去几年瑞士引进的不同疫苗之间的竞争将进一步促进信息传播和疫苗接种。
